Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni

Infection and Immunity

Volumn 65, Issue 1, 1997, Pages 219-226

  Fouad Ahmed, S ^a,c   Oswald, I P ^a,d   Caspar, P ^a   Hieny, S ^a   Keefer, L ^b   Sher, A ^a   James, S L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CAIRO UNIVERSITY   (Egypt)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SCHISTOSOMA VACCINE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIPROTOZOAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFICACY; FEMALE; INFECTION RESISTANCE; LARVAL DEVELOPMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 0009615711     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.1.219-226.1997     Document Type: Article

References (35)

1. Barrett, J. 1984. The anaerobic end-products of helminths. Parasitology 88:179-198.
2. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624.
3. Bergquist, N. R., B. F. Hall, and S. James. 1994. Schistosomiasis vaccine development: translating basic research into practical results. Immunologist 2:131-134.
4. Bohne, W., J. Heesemann, and U. Gross. 1994. Reduced replication of Toxoplasma gontdii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect. Immun. 62:1761-1767.
5. Brophy, P. M., and D. I. Pritchard. 1992. Immunity to helminths: ready to tip the biochemical balance? Parasitol. Today 8:419-422.
6. Dawson, R. M. C., D. C. Elliott, W. H. Elliott, and K. M. Jones. 1986. Antimetabolites, antibacterial agents, and enzyme inhibitors, p. 255-335. In Data for biochemical research. Clarendon Press, Oxford, United Kingdom.
7. Dean, D. A., and B. L. Mangold. 1992. Evidence that both normal and immune elimination of Schistosoma mansoni take place at the lung stage of migration prior to parasite death. Am. J. Trop. Med. Hyg. 47:238-248.
8. Dean, D. A., B. L. Mangold, J. R. Georgi, and R. H. Jacobson. 1984. Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercaria-immunized mice by means of autoradiographic analysis. Am. J. Trop. Med. Hyg. 33:89-90.
9. Foster, L. A., G.-Z. Chen, E. A. VandeWaa, R. A. Pax, and J. L. Bennett. 1989. Glutamine-vs glucose-supported motor activity in Schistosoma mansoni: physiological relevance of aerobic metabolism. Exp. Parasitol. 69:44-53.
10. James, S. L., and D. L. Boros. 1994. Immune effector role of macrophages in experimental Schistosomiasis mansoni. Immunol. Ser. 60:461-473.
11. James, S. L., and J. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208-4212.
12. James, S. L. 1992. Experimental models of immunization against schislosomes: lessons for vaccine development.Immunol. Invest. 21:477-493.
13. Kassim, O. O., D. A. Dean, B. L. Mangold, and F. von Lichtenberg. 1992. Combined microautoradiographic and histopathologic analysis of the fate of challenge Schistosoma mansoni schistosomula in mice immunized with irradiated cercariae. Am. J. Trop. Med. Hyg. 47:231-237.
14. Komuniecki, R., and P. R. Komuniecki. 1995. Aerobic-anaerobic transitions in energy metabolism during the development of the parasitic nematode Ascaris suum, p. 109-121. In J. C. Boothroyd and R. Komuniecki (ed.), Molecular approaches to parasitology. Wiley-Liss, New York, N.Y.
15. Lazdins, J. K., M. J. Stein, J. R. David, and A. Sher. 1982. Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. Exp. Parasitol. 53:39-44.
16. Mastin, A. J.. Q. D. Bickle, and R. A. Wilson. 1983. Schistosoma mansoni: migration and attrition of irradiated and challenge schistosomula in the mouse. Parasitology 87:87-102.
17. McLaren, D. J., and S. L. James. 1985. Ultrastructural studies of the killing of schistosomula of Schistosoma mansoni by activated macrophages in vitro. Parasite Immunol. 7:315-331.
18. Mooradiana D. L., T. C. Hutsell, and L. K. Keefer. 1995. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 25:674-678.
19. Oswald, I. P., I. Eltoum, T. A. Wynn, B. Schwartz, P. Caspar, D. Paulin, A. Sher, and S. L. James. 1994. Endothelial cells are activated by cytokine treatment to kill an intravascular parasite. Schistosoma mansoni. through the production of nitric oxide. Proc. Natl. Acad. Sci. USA 91:999-1003.
20. Pearce, E. J., and S. L. James. 1986. Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol. 8:513-527.
21. Sher, A., S. L. James, A. J. G. Simpson, J. K. Lazdins, and M. S. Meltzer. 1982. Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediatcd killing during maturation of S. mansoni schistosomula from the skin to the lung stage. J. Immunol. 128:1876-1879.
22. Sher, A., and G. Moser. 1981. Immunologic properties of developing schistosomula. Am. J. Pathol. 102:121-126.
23. Skelly, P. J., L. D. Stein, and C. B. Shoemaker. 1993. Expression of Schistosoma mansoni genes involved in anaerobic and oxidative glucose metabolism during the cercaria to adult transformation. Mol. Biochem. Parasitol. 60:43-104.
24. Smithers, S. R., and R. J. Terry. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitology 55:695-700.
25. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1992. Monoclonal antibody to IFN modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:3054-3658.
26. Slamler, J. S., D. J. Singel, and J. Loscalzo. 1992 Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902.
27. Thompson, D. P., D. D. Morrison, R. A Pax, and J. L. Bennett. 1984. Changes in glucose metabolism and cyanide sensitivity in Schistosoma mansoni during development. Mol. Biochem. Parasitol. 13:39-51.
28. Tielens, A. G. M. 1994. Energy generation in parasitic helminths. Parasitol. Today 10:346-352.
29. Vanden Bossche, H. 1985. How anthelminties help us to understand helminths. Parasitology 90:675-685.
30. Van Oordt, B. E. P., A. G. M. Tielens, and S. G. van den Bergh. 1988. The energy metabolism of Schistosoma mansoni during its Development in the hamster. Parasitol. Res. 75:31-35.
31. Williams, M. E., P. Caspar, I. Oswald, H. K. Sharma, O. Pankewycz, A. Sher, and S. L. James. 1995. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β. which down-regulates macrophage antiparasitic activity. J. Immunol. 154:4693-4700.
32. Wilson, R. A., and P. S. Coulson. 1989. Lung-phase immunity to schistosomes: a new perspective on an old problem. Parasitol. Today 5:274-278.
33. Woods, M. L., J. Mayor, T. G. Evans, and J. B. Hibbs Jr. 1994. Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania infection. Immunol. Ser. 60:179-195.
34. World Health Organization. 1993. The control of schistosomiasis. In Second Report of the WHO Expert Committee. World Health Organization. Geneva. Switzerland.
35. Wynn, T. A., I. P. Oswald, I. A. Eltoum, P. Caspar, C. J. Lowenstein, F. A. Lewis, S. L. James, and A. Sher. 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:5200-5209.